Placeholder Banner

Congressional Letter to FDA Commissioner Sharpless on Animal Biotech

July 26, 2019

In recent years advances in animal genetics have provided significant breakthroughs that can help to address some of society's most difficult challenges. These technologies can treat and protect animals from illness; limit the transmission of dangerous diseases, like African swine fever or avian influenza; curb the use of antibiotics in agriculture; address hunger and insect-borne disease in developing nations; improve animal welfare; among many other benefits. 


While we think a robust conversation should be had on the best way to provide transparency to consumers and users on the nature of these animals, that discussion will be moot if our nation's regulatory system prevents these animals from coming to market. We again urge you to work with other relevant agencies and stakeholder communities to develop a more appropriate, workable approach that will provide sufficient safeguards, while allowing U.S. farmers, consumers, and the public health officials access to animal innovations. 

Download Full Comments Below
Congressional Letter to FDA on Animal Biotech
Discover More
BIO understands that consumers want more information about what is in their food and whether their food is safe. Our members will be a driver of that…
We urge you to direct the EPA to reject all calls to waive the RFS. The RFS is more important now than ever as farmers, the biofuel sector, and rural America struggle to remain operating amid the COVID-19 crisis.
Undermining the RFS at a time when rural America is struggling economically, farmers are fighting to stay in business, and the biofuels industry has been impacted by furloughs and plant closures is unconscionable. We respectfully urge you to reject…